Navigation Links
Forest Laboratories, Inc. and Merz Pharma GmbH & Co. KgaA File Lawsuits Against Several Companies for Patent Infringement
Date:1/10/2008

NEW YORK, Jan. 10 /PRNewswire-FirstCall/ -- Forest Laboratories, Inc. (NYSE: FRX), Forest Laboratories Holdings, Ltd., Merz Pharma GmbH & Co. KgaA, and Merz Pharmaceuticals GmbH announced that they have filed lawsuits in the U.S. District Court for the District of Delaware against several companies for infringement of U.S. Patent No. 5,061,703 (the '703 patent), which relates to Forest's Namenda(R) product. The defendants named in the lawsuits include Barr Laboratories, Inc., Cobalt Laboratories, Inc., Lupin Ltd., Orchid Chemicals & Pharmaceuticals Ltd., Teva Pharmaceuticals USA, Inc., Upsher-Smith Laboratories Inc., Wockhardt Ltd., and related companies and subsidiaries thereof. The '703 patent expires in April 2010. Forest has applied for patent term extension which, if granted, would extend the '703 patent until September 2013.

(Logo: http://www.newscom.com/cgi-bin/prnh/20001011/FORESTLOGO )

As previously reported, Forest had received notification from several companies that they had filed Abbreviated New Drug Applications with Paragraph IV certifications to obtain approval to market generic versions of Namenda.

Except for the historical information contained herein, this release contains forward-looking statements within the meaning of the Private Securities Litigation Reform act of 1995. These statements involve a number of risks and uncertainties, including the difficulty of predicting FDA approvals, the acceptance and demand for new pharmaceutical products, the impact of competitive products and pricing, the timely development and launch of new products, and the risk factors listed from time to time in each of Forest Laboratories
'/>"/>

SOURCE Forest Laboratories, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Out of the woods: Physicians get urban disaster training in forests, gorges and waters
2. Forest Laboratories, Inc. Sets Date and Conference Call for Fiscal 2008 Second Quarter Earnings
3. Parasites a key to the decline of red colobus monkeys in forest fragments
4. Forest Laboratories and Cypress Bioscience to Host Webcast to Discuss Clinical Data Presentations for Milnacipran
5. Abbott Donates Cool Globe to Lake County Forest Preserves for Permanent Display at Greenbelt Cultural Center
6. Forest Laboratories, Inc. Sets Date and Conference Call for Fiscal 2008 Third Quarter Earnings
7. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
8. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Adipex-P(R)
9. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Coreg(R)
10. Roxane Laboratories, Inc. Announces the Launch of Oxcarbazepine Tablets, 150mg, 300mg and 600mg
11. Caraco Pharmaceutical Laboratories, Ltd. Announces Tentative FDA Approval for Generic Lamictal(R)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... According to a new market research report "Near ... and Auxiliary), Application (Payment, Transportation, Booking, Data Sharing, Service, ... Geography - Global Forecasts to 2022", published by MarketsandMarkets, ... Billion by 2022 at an estimated CAGR of 8.83% ... Tables and 105 Figures spread through 298 Pages and ...
(Date:8/21/2014)... 21, 2014 It's a terrible thing when ... to a serious substance abuse issue. When that happens to ... action is getting reliable help from the qualified substance abuse ... facility isn’t always easy for those young adults living in ... significant addiction issue. , Thankfully there is a new ...
(Date:8/21/2014)... Rockville, Maryland (PRWEB) August 21, 2014 ... developed with guidance from Lockton Companies and builds ... the industry’s only cellular glucometer, combined with Accountable ... and robust data analytic capabilities and adds a ... provider care, including eye exams, provider visits, HbA1c ...
(Date:8/21/2014)... (PRWEB) August 21, 2014 Sleep Apnea Doctors ... the U.S. This provides doctors with a convenient way to ... a doctor are that much closer to finding remedies ... no idea they are experiencing this sleep disorder , ... treatment at all. , Thanks to Sleep Apnea Doctors U.S., ...
(Date:8/21/2014)... (PRWEB) August 21, 2014 Relias Learning, ... the health and human services markets, announced the latest ... capabilities incorporating the Tin Can API. , “Supporting ... employees have the most advanced mobile learning capabilities and ... adult learning tools and techniques,” says Jim Triandiflou, CEO ...
Breaking Medicine News(10 mins):Health News:Near Field Communication Market by Product (IC/Chips, Tags, Readers, and Auxiliary) Worth $16.25 Billion by 2022 – New Report by MarketsandMarkets 2Health News:Near Field Communication Market by Product (IC/Chips, Tags, Readers, and Auxiliary) Worth $16.25 Billion by 2022 – New Report by MarketsandMarkets 3Health News:Near Field Communication Market by Product (IC/Chips, Tags, Readers, and Auxiliary) Worth $16.25 Billion by 2022 – New Report by MarketsandMarkets 4Health News:Young Adults in Pompano Beach, FL Are Finding Success With Innovative New Helpline 2Health News:Accountable Health Expands Diabetes Management Solutions to Address Gaps in Provider Care 2Health News:Accountable Health Expands Diabetes Management Solutions to Address Gaps in Provider Care 3Health News:Sleep Apnea Doctors US is Now Offering Complimentary Listings to Sleep Apnea Doctors Across the United States 2Health News:Relias Learning Announces Support for Tin Can API 2
... (HealthDay News) -- Infants with Down syndrome who weigh less than ... lung disorders that increase their chances of dying, a new study ... than 50,000 very low birth weight (VLBW) infants who weighed between ... this group of babies, those born with Down syndrome were about ...
... that control the age of sexual maturation in women. ... weight regulation or biological pathways related to fat metabolism. ... was a collaborative effort by the international ReproGen consortium, ... Boston University School of Medicine (BUSM) and Boston University ...
... 1. Low Income Individuals Are Donating Fewer Kidneys ,Kidney ... Research shows that people with low incomes are ... receive a living donor kidney transplant than people of other ... kidneys, Jagbir Gill, MD (St. Paul,s Hospital, University of British ...
... HealthDay Reporter , FRIDAY, Nov. 19 (HealthDay News) -- ... from the U.S. market because they,ve been linked to ... Friday. The U.S. Food and Drug Administration said ... is voluntarily taking the drugs off the market. The ...
... , FRIDAY, Nov. 19 (HealthDay News) -- A new, small ... doctors determine the best dose of tamoxifen, a drug commonly used ... that the body absorbs cough medicine at about the same rate ... respond to the breast-cancer drug. "This study is starting ...
... 16, 2010) A clinical trial that aims to speed ... of breast cancer now has a designated study site ... University of Colorado Hospital. This study, called I-SPY ... Response with Imaging and Molecular Analysis 2) will evaluate ...
Cached Medicine News:Health News:Tiniest Newborns With Down Syndrome Face Other Health Risks 2Health News:Genes link puberty timing and body fat in women 2Health News:Efforts needed to address disparities in kidney transplantation 2Health News:Efforts needed to address disparities in kidney transplantation 3Health News:Efforts needed to address disparities in kidney transplantation 4Health News:FDA Pulls Darvon and Companion Drug Due to Heart Risks 2Health News:FDA Pulls Darvon and Companion Drug Due to Heart Risks 3Health News:Cough Syrup Might Help With Dosing of Breast Cancer Drug 2Health News:I-SPY 2 study speeds up treatment for breast cancer 2Health News:I-SPY 2 study speeds up treatment for breast cancer 3
(Date:8/21/2014)... - Bedrocan Cannabis Corp., previously Bedrocan Canada Inc. ("Bedrocan") ... of Directors, enhancing executive oversight and strengthening the ... licensed producer of medicinal cannabis in ... experience in producing and supplying government-regulated pharmaceutical-grade cannabis ... As previously announced in a press ...
(Date:8/21/2014)... CYBX ) today announced results for the quarter ended ... Operating results for the first quarter of fiscal ... other achievements, include: , Worldwide net product sales of ... net sales of $13.2 million, an increase of 14.5% on ... reached a new high of $58.8 million, an increase of ...
(Date:8/21/2014)... Calif. , Aug. 21, 2014 Asterias ... the emerging field of regenerative medicine, announced today the ... to the Company,s newly expanded Board of Directors. With ... eight directors, three of whom are independent. ... experience working with emerging growth companies. He is currently ...
Breaking Medicine Technology:Senior Life Sciences Executives Join Bedrocan as Independent Directors 2Senior Life Sciences Executives Join Bedrocan as Independent Directors 3Cyberonics Reports Fiscal 2015 First Quarter Results 2Cyberonics Reports Fiscal 2015 First Quarter Results 3Cyberonics Reports Fiscal 2015 First Quarter Results 4Cyberonics Reports Fiscal 2015 First Quarter Results 5Cyberonics Reports Fiscal 2015 First Quarter Results 6Cyberonics Reports Fiscal 2015 First Quarter Results 7Cyberonics Reports Fiscal 2015 First Quarter Results 8Cyberonics Reports Fiscal 2015 First Quarter Results 9Cyberonics Reports Fiscal 2015 First Quarter Results 10Cyberonics Reports Fiscal 2015 First Quarter Results 11Cyberonics Reports Fiscal 2015 First Quarter Results 12Cyberonics Reports Fiscal 2015 First Quarter Results 13Cyberonics Reports Fiscal 2015 First Quarter Results 14Cyberonics Reports Fiscal 2015 First Quarter Results 15Cyberonics Reports Fiscal 2015 First Quarter Results 16Asterias Biotherapeutics Appoints Two Independent Directors and Announces Completion of Series A Common Stock Distribution 2Asterias Biotherapeutics Appoints Two Independent Directors and Announces Completion of Series A Common Stock Distribution 3Asterias Biotherapeutics Appoints Two Independent Directors and Announces Completion of Series A Common Stock Distribution 4
... today,announced that its WaveReady 3000 series has ... compatible with Brocade-based Storage Area,Network (SAN) infrastructures ... Data Center Ready Program. The program is ... Brocade-based data center,environments., "We are pleased ...
... Covers Compositions and Methods, ROCKVILLE, Md., June ... clinical-stage pharmaceutical company developing,therapeutics for the treatment of ... U.S. Patent No. 7,371,741 covering analogs of 2-,methoxyestradiol ... use intellectual property protection through 2025 for analogs,of ...
Cached Medicine Technology:JDSU WaveReady Receives Brocade Data Center Ready Status for Brocade-Based Storage Area Network (SAN) Infrastructures 2JDSU WaveReady Receives Brocade Data Center Ready Status for Brocade-Based Storage Area Network (SAN) Infrastructures 3EntreMed Receives New Patent for 2-Methoxyestradiol Analogs 2EntreMed Receives New Patent for 2-Methoxyestradiol Analogs 3
Desmarres Retractor Size 4...
Desmarres Lid Retractor thin solid blades. Size 2....
... system introduces a new level ... microsurgical instrumentation. It has an ... with advanced microcomputer control of ... operate with a full range ...
Multiple Modulation Phaco (MMP) programmability with eight surgeon settings for maximum versatility. The combination of the peristaltic power balanced pump and the piezoelectric handpiece results in ...
Medicine Products: